A new report by XploreMR studies the growth drivers, trends, restraints, and highlights of the global vascular closure device market. Presenting exclusive insights into the market from 2017 to 2022, the report projects that the market will witness notable growth during the forecast period. Vascular closure devices (VCDs) are designed to seal the punctured artery after the angiogram process. The insertion of VCDs is a simple process that reduces recovery time and improves patient satisfaction. VCDs are preferred over other conventional methods, owing to their high efficiency and success rate. The growth of the market is driven by the rising prevalence of cardiovascular diseases, increased rate of obesity, and regulatory approvals on new products. Moreover, increasing the adoption of femoral artery cardiac catheterization, coupled with a high success rate of VCDs in improving patient comfort is also complementing the growth of the market.

Ease of Use and Time Effective Nature of VDCs Burgeons Usage

Over the years, the popularity of VCDs has significantly increased, and are gradually replacing traditional compression methods, on the back of their time-effectiveness and ease of usage. VCDs instantaneously seal the femoral artery access unlike manual or mechanical compression methods, which are time-consuming. Furthermore, VCDs are capable of effortlessly overcoming the involved complications of manual methodologies, such as prolonged bed rest and patient discomfort. This patient-friendly nature of VCDs is expected to remain the major driving factor of the growth of the vascular closure device market. Moreover, VCDs are used in the diagnosis and therapies of coronary heart disease, which will further push the revenue of the market. On the other hand, poor quality, devices malfunction, and underperformance of poorly manufactured devices are creating negative perception regarding the dependability of these devices and is affecting the adoption to an extent.

North America Remains at Forefront of Market Growth

North America is expected to maintain hegemony over the regional landscape of the VCD market, backed by the high incidence of lifestyle diseases, and favorable government initiatives to develop innovative technologies. Besides, the preference among consumers for minimally-invasive solutions and increased catheterization processes are also fuelling market growth. On the other hand,  growth in emerging economies, such as the Asia Pacific and South America remains on the lower side owing to restraining factors such as high price of treatments, and lower adoption rates of innovative technologies.